Oxycodone Pregnancy and Breastfeeding Warnings

Oxycodone is also known as: Dazidox, ETH-Oxydose, Endocodone, M-Oxy, Oxecta, OxyContin, OxyIR, Oxydose, Oxyfast, Percolone, Roxicodone, Roxicodone Intensol

Oxycodone Pregnancy Warnings

Use is contraindicated for some formulations of this drug. Consult product information. (AU, UK) This drug should not be used unless there are no safer alternatives. (AU, UK, US) AU TGA pregnancy category: C US FDA pregnancy category: B Comments: Adequate methods of contraception should be encouraged.

Opioid analgesics cross the placenta. The use of this drug during labor may cause respiratory depression in the newborn infant. Babies born to opioid-dependent mothers may be physically dependent and suffer withdrawal symptoms (e.g., convulsions, irritability, excessive crying, tremors, hyperactive reflexes, fever, vomiting, diarrhea, sneezing, yawning). AU TGA pregnancy category C: Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible. Accompanying texts should be consulted for further details. US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

Oxycodone Breastfeeding Warnings

Maternal use of narcotics during breastfeeding can cause infant drowsiness, central nervous system depression, and even death. Infant sedation is common with maternal use of this drug. Newborn infants are particularly sensitive to the effects of even small dosages of narcotic analgesics. It is best to provide pain control with a nonnarcotic analgesic if possible and limit maternal intake of this drug to a few days. A maximum dosage of 30 mg daily is suggested. The infant should be monitored closely for drowsiness, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants.

Use is contraindicated for some formulations of this drug. Consult product information. (AU, UK) This drug should not be used unless there are no safer alternatives. (AU, UK, US) Excreted into human milk: Yes Comments: Breastfed infants should be monitored for sedation, respiratory depression, poor attachment, and withdrawal effects upon maternal cessation of this drug.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web3)